Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 6/20 | 0.80 |
| ▸ | CNR1 | P21554 | 4/20 | 0.80 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5553149 | 1.00 | CNR2 (0.80) | CNR2CNR1EPHX1PPARGPPARD | |
| SCHEMBL1946504 | 1.00 | CNR2 (0.80) | CNR2CNR1EPHX1PPARGPPARD | |
| SCHEMBL258448 | 1.00 | CNR2 (0.80) | CNR2CNR1EPHX1PPARGPPARD | |
| SCHEMBL20883258 | 1.00 | CNR2 (0.80) | CNR2CNR1EPHX1PPARGPPARD | |
| SCHEMBL20883283 | 1.00 | CNR2 (0.80) | CNR2CNR1EPHX1PPARGPPARD | |
| SCHEMBL5553152 | 1.00 | CNR2 (0.80) | CNR2CNR1EPHX1PPARGPPARD | |
| SCHEMBL1030756 | 1.00 | CNR2 (0.80) | CNR2CNR1EPHX1PPARGPPARD | |
| SCHEMBL4205215 | 0.95 | CNR2 (0.73) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL29406024 | 0.90 | CNR2 (0.66) | CNR2CNR1PPARGPPARDPPARA | |
| SCHEMBL2262688 | 0.89 | CNR2 (1.00) | CNR2CNR1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066320-A1 | Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same | SYMRISE AG (DE) | 2025-02-27 | — | — | US | claimed |
| EP-3969163-B1 | BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | claimed |
| EP-4452941-A1 | ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-10-30 | — | — | EP | claimed |
| EP-1517880-B1 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | SYMRISE AG (DE) | 2011-01-05 | — | — | EP | claimed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-20250144589-A1 | Method for Producing Microcapsules | SYMRISE AG (DE) | 2025-05-08 | — | — | US | disclosed |
| US-20250066320-A1 | Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same | SYMRISE AG (DE) | 2025-02-27 | — | — | US | disclosed |
| EP-4472763-A1 | METHOD FOR PRODUCING MICROCAPSULES | Symrise AG (DE) | 2024-12-11 | — | — | EP | disclosed |
| EP-3969163-B1 | BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | disclosed |
| EP-4452941-A1 | ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-10-30 | — | — | EP | disclosed |
| US-20240293790-A1 | Biodegradable Polyurea/Polyurethane Microcapsules | SYMRISE AG (DE) | 2024-09-05 | — | — | US | disclosed |
| EP-4378575-A1 | POLYUREA/POLYURETHANE MICROCAPSULES | Symrise AG (DE) | 2024-06-05 | — | — | EP | disclosed |
| WO-2006032664-A1 | USE OF ISOEUGENOL METHYL ETHER AS AN AGENT AGAINST BAD BREATH | SYMRISE GMBH & CO. KG (DE) | 2006-03-30 | — | — | WO | disclosed |
| US-20050244561-A1 | Carvone acetals used as flavourings | SYMRISE GMBH & CO. KG (DE) | 2005-11-03 | — | — | US | disclosed |
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | SYMRISE AG (DE) | 2005-10-20 | — | — | US | disclosed |
| US-20050208084-A1 | Use of alkylamidomandelates as flavourings | SYMRISE GMBH & CO. KG (DE) | 2005-09-22 | — | — | US | disclosed |
| US-20040241312-A1 | Use of 2E,4E-decadienoic acid isobutylamide for imparting a salivation inducing effect to a foodstuff, an oral hygiene preparation or a gourmet or snack preparation; preparation by amidating a dodecadienoate with isobutylamine | SYMRISE AG (DE) | 2004-12-02 | — | — | US | disclosed |
| US-6673756-B2 | MULTILAYER; CUTTING, JOINING UNDER PRESSURE | SYMRISE GMBH & CO. KG (DE) | 2004-01-06 | — | — | US | disclosed |
| US-20030152682-A1 | Use of ferulic acid amides as flavor compounds | SYMRISE AG (DE) | 2003-08-14 | — | — | US | disclosed |
| US-20020173436-A1 | Multilayer; cutting, joining under pressure | SYMRISE GMBH & CO. KG (DE) | 2002-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | NISCH, CYP8B1, DLAT | CNR2 2674/4885CNR1 3549/4885EPHX1 896/4885 |
| US-20050208084-A1 | Use of alkylamidomandelates as flavourings | HNMT, TAS2R7, PNMT | CNR2 83/4885CNR1 158/4885EPHX1 1804/4885 |
| US-20250066320-A1 | Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same | TAS2R5, TAS2R7, TAS2R8 | CNR2 3211/4885CNR1 2662/4885EPHX1 2617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.